The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Characterization of signal transduction and glucose transport in skeletal muscle from type 2 diabetic patients
Open accessAbstract
We characterized metabolic and mitogenic signaling pathways in isolated skeletal muscle from well-matched type 2 diabetic and control subjects. Time course studies of the insulin receptor, insulin receptor substrate (IRS)-1/2, and phosphatidylinositol (PI) 3-kinase revealed that signal transduction through this pathway was engaged between 4 and 40 min. Insulin-stimulated (0.6-60 nmol/l) tyrosine phosphorylation of the insulin receptor beta-subunit, mitogen-activated protein (MAP) kinase phosphorylation, and glycogen synthase activity were not altered in type 2 diabetic subjects. In contrast, insulin-stimulated tyrosine phosphorylation of IRS-1 and anti-phosphotyrosine-associated PI 3-kinase activity were reduced 40-55% in type 2 diabetic subjects at high insulin concentrations (2.4 and 60 nmol/l, respectively). Impaired glucose transport activity was noted at all insulin concentrations (0.6-60 nmol/l). Aberrant protein expression cannot account for these insulin-signaling defects because expression of insulin receptor, IRS-1, IRS-2, MAP kinase, or glycogen synthase was similar between type 2 diabetic and control subjects. In skeletal muscle from type 2 diabetic subjects, IRS-1 phosphorylation, PI 3-kinase activity, and glucose transport activity were impaired, whereas insulin receptor tyrosine phosphorylation, MAP kinase phosphorylation, and glycogen synthase activity were normal. Impaired insulin signal transduction in skeletal muscle from type 2 diabetic patients may partly account for reduced insulin-stimulated glucose transport; however, additional defects are likely to play a role.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Maintaining the integrity of the IRS-1/PI-3 kinase/Akt pathway is essential for normal insulin-mediated glucose uptake in skeletal muscle ( 26 ).”
From Skeletal Muscle Insulin Resistance Is the Primary Defect in Type 2 Diabetes (2009) · cites this paper as [26]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Using the euglycemic insulin clamp with skeletal muscle biopsy, a number of investigators have examined the insulin signal transduction system in human skeletal muscle of type 2 diabetic subjects and consistently demonstrated defects in IRS-1 tyrosine phosphorylation and PI-3 kinase and Akt activation ( 26 , 54 , 55 ).”
From Skeletal Muscle Insulin Resistance Is the Primary Defect in Type 2 Diabetes (2009) · cites this paper as [26]
Experimental — accuracy not yet measuredIn the citing paper
“Association of the p85 subunit of PI3K with IRS-1 and activation of PI3K also are greatly attenuated in obese nondiabetic and type 2 diabetic subjects compared with lean healthy controls [7, 165, 166].”
From Pathogenesis of insulin resistance in skeletal muscle (2010) · cites this paper as [165]
In the citing paper
“Insulin resistance in the PI3K signaling pathway contrasts with an intact stimulation of the MAPK pathway by insulin in insulin-resistant type 2 diabetic and obese nondiabetics individuals [7, 165].”
From Pathogenesis of insulin resistance in skeletal muscle (2010) · cites this paper as [165]
In the citing paper
“In insulin resistant individuals with T2DM, glucose transport activity is severely impaired [156, 181, 182, 187–189].”
From Pathogenesis of insulin resistance in skeletal muscle (2010) · cites this paper as [189]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Structure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein
Sun, X. J., Rothenberg, P., Kahn, C. R., Backer, J. M., Araki, E., Wilden, P. A., Cahill, D. A., Goldstein, B. J., & White, M. F. (1991) · Nature · doi:10.1038/352073a0 · Cited by 1,574
Thomas, J. A., Schlender, K. K., & Larner, J. (1968) · Analytical Biochemistry · doi:10.1016/0003-2697(68)90127-9 · Cited by 1,198
DeFronzo, R. A., Gunnarsson, R., Björkman, O., Olsson, M., & Wahren, J. (1985) · Journal of Clinical Investigation · doi:10.1172/jci111938 · Cited by 1,167
Goodyear, L. J., Giorgino, F., Sherman, L., Carey, J., Smith, R. J., & Dohm, G. L. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117909 · Cited by 527
Garvey, W. T., Maianu, L., Zhu, J. H., Brechtel-Hook, G., Wallace, P., & Baron, A. D. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1557 · Cited by 459
A microfluorometric method for the determination of free fatty acids in plasma
Miles, J., Glasscock, R., Aikens, J., Gerich, J. E., & Haymond, M. W. (1983) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38029-9 · Cited by 329
Rothman, D. L., Shulman, R. G., & Shulman, G. I. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115686 · Cited by 327
Vaag, A., Henriksen, J. E., & Beck-Nielsen, H. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115656 · Cited by 299
Dohm, G. L., Tapscott, E. B., Pories, W. J., Dabbs, D. J., Flickinger, E. G., Meelheim, D., Fushiki, T., Atkinson, S., Elton, C. W., & Caro, J. F. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113622 · Cited by 296
Kelley, D. E., Mintun, M. A., Watkins, S. C., Simoneau, J. A., Jadali, F., Fredrickson, A., Beattie, J., & Thériault, R. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118724 · Cited by 228
Cited by
Sorted by citations
DeFronzo, R. A. (2009) · Diabetes · doi:10.2337/db09-9028 · Cited by 3,016
Mechanisms of Insulin Action and Insulin Resistance
Petersen, M. C., & Shulman, G. I. (2018) · Physiological Reviews · doi:10.1152/physrev.00063.2017 · Cited by 3,028
DeFronzo, R. A., Ferrannini, E., Groop, L., Henry, R. R., Herman, W. H., Holst, J. J., Hu, F. B., Kahn, C. R., Raz, I., Shulman, G. I., et al. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.19 · Cited by 2,611
Skeletal Muscle Insulin Resistance Is the Primary Defect in Type 2 Diabetes
DeFronzo, R. A., & Tripathy, D. (2009) · Diabetes Care · doi:10.2337/dc09-s302 · Cited by 2,102
“Maintaining the integrity of the IRS-1/PI-3 kinase/Akt pathway is essential for normal insulinmediated glucose uptake in skeletal muscle (26).”
BackgroundPathogenesis of type 2 diabetes mellitus
DeFronzo, R. A. (2004) · Medical Clinics of North America · doi:10.1016/j.mcna.2004.04.013 · Cited by 1,342
Signaling Pathways in Skeletal Muscle Remodeling
Bassel‐Duby, R., & Olson, E. N. (2006) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.75.103004.142622 · Cited by 823
Pathogenesis of insulin resistance in skeletal muscle
Abdul-Ghani, M. A., & DeFronzo, R. A. (2010) · Journal of Biomedicine and Biotechnology · doi:10.1155/2010/476279 · Cited by 670
Ceramide Content Is Increased in Skeletal Muscle From Obese Insulin-Resistant Humans
Adams, J. M., Pratipanawatr, T., Berria, R., Wang, E. L., DeFronzo, R. A., Sullards, M. C., & Mandarino, L. J. (2004) · Diabetes · doi:10.2337/diabetes.53.1.25 · Cited by 677
Holten, M. K., Zacho, M., Gaster, M., Juel, C., Wojtaszewski, J. F. P., & Dela, F. (2004) · Diabetes · doi:10.2337/diabetes.53.2.294 · Cited by 615
Engineered In Vitro Disease Models
Benam, K. H., Dauth, S., Hassell, B., Herland, A., Jain, A., Jang, K.-J., Karalis, K., Kim, H. J., MacQueen, L., Mahmoodian, R., et al. (2015) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-012414-040418 · Cited by 554
Invited Review: Effects of acute exercise and exercise training on insulin resistance
Henriksen, E. J. (2002) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01219.2001 · Cited by 535
Insulin action and insulin resistance in human skeletal muscle
Zierath, J. R., Krook, A., & Wallberg-Henriksson, H. (2000) · Diabetologia · doi:10.1007/s001250051457 · Cited by 367
Self-citationExercise as a therapeutic intervention for the prevention and treatment of insulin resistance
Hawley, J. A. (2004) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.505 · Cited by 344
Parpal, S., Karlsson, M., Thorn, H., & Strålfors, P. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m007454200 · Cited by 339
Recent Advances in Our Understanding of Insulin Action and Insulin Resistance
Roith, D. L., & Zick, Y. (2001) · Diabetes Care · doi:10.2337/diacare.24.3.588 · Cited by 347
Defects in insulin receptor signaling in vivo in the polycystic ovary syndrome (PCOS)
Dunaif, A., Wu, X., Lee, A., & Diamanti-Kandarakis, E. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.281.2.e392 · Cited by 337
Potenza, M. A., Marasciulo, F. L., Chieppa, D. M., Brigiani, G. S., Formoso, G., Quon, M. J., & Montagnani, M. (2005) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00092.2005 · Cited by 314
Bouzakri, K., Roques, M., Gual, P., Espinosa, S., Guebre-Egziabher, F., Riou, J.-P., Laville, M., Le Marchand-Brustel, Y., Tanti, J.-F., & Vidal, H. (2003) · Diabetes · doi:10.2337/diabetes.52.6.1319 · Cited by 305
Skeletal muscle tissue engineering: methods to form skeletal myotubes and their applications
Ostrovidov, S., Hosseini, V., Ahadian, S., Fujie, T., Parthiban, S. P., Ramalingam, M., Bae, H., Kaji, H., & Khademhosseini, A. (2014) · Tissue Engineering Part B: Reviews · doi:10.1089/ten.teb.2013.0534 · Cited by 302
Karlsson, H., Zierath, J. R., Kane, S., Krook, A., Lienhard, G. E., & Wallberg‐Henriksson, H. (2005) · Diabetes · doi:10.2337/diabetes.54.6.1692 · Cited by 299
Self-citationCurrent Concepts in the Polycystic Ovary Syndrome
Dunaif, A. E., & Thomas, A. (2001) · Annual Review of Medicine · doi:10.1146/annurev.med.52.1.401 · Cited by 303
Low birthweight is associated with specific changes in muscle insulin-signalling protein expression
Ozanne, S. E., Jensen, C. B., Tingey, K., Storgaard, H., Madsbad, S., & Vaag, A. A. (2005) · Diabetologia · doi:10.1007/s00125-005-1669-7 · Cited by 290
Pathophysiology of insulin resistance
Sesti, G. (2006) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2006.09.007 · Cited by 297
Pirola, L., Johnston, A., & OBBERGHEN, E. V. (2004) · Diabetologia · doi:10.1007/s00125-003-1313-3 · Cited by 286
Corbould, A., Kim, Y.-B., Youngren, J. F., Pender, C., Kahn, B. B., Lee, A., & Dunaif, A. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00361.2004 · Cited by 283
Adipose tissue and its role in organ crosstalk
Romacho, T., Elsen, M., Röhrborn, D., & Eckel, J. (2014) · Acta Physiologica · doi:10.1111/apha.12246 · Cited by 292
Signalling aspects of insulin resistance in skeletal muscle
Schmitz‐Peiffer, C. (2000) · Cellular Signalling · doi:10.1016/s0898-6568(00)00110-8 · Cited by 269
Regulation by Insulin of Gene Expression in Human Skeletal Muscle and Adipose Tissue
Ducluzeau, P., Peretti, N., Laville, M., Andréelli, F., Véga, N., Riou, J. P., & Vidal, H. (2001) · Diabetes · doi:10.2337/diabetes.50.5.1134 · Cited by 263
S-Nitrosylation-dependent Inactivation of Akt/Protein Kinase B in Insulin Resistance
Yasukawa, T., Tokunaga, E., Ota, H., Sugita, H., Martyn, J. A. J., & Kaneki, M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m411871200 · Cited by 265
Hwang, H., Bowen, B. P., Lefort, N., Flynn, C. R., De Filippis, E. A., Roberts, C., Smoke, C. C., Meyer, C., Højlund, K., Yi, Z., et al. (2010) · Diabetes · doi:10.2337/db09-0214 · Cited by 255
Alterations of insulin signaling in type 2 diabetes: A review of the current evidence from humans
Fröjdö, S., Vidal, H., & Pirola, L. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2008.10.019 · Cited by 247
Programming of glucose-insulin metabolism in adult sheep after maternal undernutrition
Gardner, D. S., Tingey, K., van Bon, B. W. M., Ozanne, S. E., Wilson, V., Dandrea, J., Keisler, D. H., Stephenson, T. J., & Symonds, M. E. (2005) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00120.2005 · Cited by 241
Koistinen, H. A., Galuska, D., Chibalin, A., Yang, J., Zierath, J. R., Holman, G. D., & Wallberg‐Henriksson, H. (2003) · Diabetes · doi:10.2337/diabetes.52.5.1066 · Cited by 232
Self-citationChibalin, A. V., Leng, Y., Vieira, E., Krook, A., Björnholm, M., Long, Y. C., Kotova, O., Zhong, Z., Sakane, F., Steiler, T., et al. (2008) · Cell · doi:10.1016/j.cell.2007.12.035 · Cited by 232
Self-citationOzanne, S. E., Olsen, G., Hansen, L., Tingey, K., NAVÉ, B. T., Wang, C., Hartil, K., Petry, C. J., Buckley, A., & Mosthaf, L. (2003) · Journal of Endocrinology · doi:10.1677/joe.0.1770235 · Cited by 230
O’Gorman, D. J., Karlsson, H. K. R., McQuaid, S., Yousif, O., Rahman, Y., Gasparro, D., Glund, S., Chibalin, A. V., Zierath, J. R., & Nolan, J. J. (2006) · Diabetologia · doi:10.1007/s00125-006-0457-3 · Cited by 226
Self-citationEnhanced Basal Activation of Mitogen-Activated Protein Kinases in Adipocytes From Type 2 Diabetes
Carlson, C. J., Koterski, S., Sciotti, R. J., Poccard, G. B., & Rondinone, C. M. (2003) · Diabetes · doi:10.2337/diabetes.52.3.634 · Cited by 230
Invited Review: Exercise training-induced changes in insulin signaling in skeletal muscle
Zierath, J. R. (2002) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00126.2002 · Cited by 215
Self-citationBouzakri, K., Zachrisson, A., Al‐Khalili, L., Zhang, B. B., Koistinen, H. A., Krook, A., & Zierath, J. R. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.04.008 · Cited by 222
Self-citationDelarue, J., Foll, C. L., Corporeau, C., & Lucas, D. (2004) · annales de biologie animale biochimie biophysique · doi:10.1051/rnd:2004033 · Cited by 205
Symonds, M. E., Stephenson, T. J., Gardner, D. S., & Budge, H. (2006) · Reproduction Fertility and Development · doi:10.1071/rd06130 · Cited by 211
(2006) · doi:10.1016/j.tem.2006.01.005 · Cited by 256
PTP1B and TCPTP – nonredundant phosphatases in insulin signaling and glucose homeostasis
Tiganis, T. (2012) · FEBS Journal · doi:10.1111/j.1742-4658.2012.08563.x · Cited by 209
Massart, J., Sjögren, R. J. O., Lundell, L. S., Mudry, J. M., Franck, N., O’Gorman, D. J., Egan, B., Zierath, J. R., & Krook, A. (2017) · Diabetes · doi:10.2337/db17-0141 · Cited by 201
Self-citationClark, M. G. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90477.2008 · Cited by 195
Muscle and adipose tissue insulin resistance: malady without mechanism?
Fazakerley, D. J., Krycer, J. R., Kearney, A. L., HOCKING, S. L., & James, D. E. (2018) · Journal of Lipid Research · doi:10.1194/jlr.r087510 · Cited by 188
Huang, C., Thirone, A. C. P., Huang, X., & Klip, A. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m412317200 · Cited by 181
Diabetes Reduces Basal Retinal Insulin Receptor Signaling
Reiter, C. E. N., Wu, X., Sandirasegarane, L., Nakamura, M., Gilbert, K. A., Singh, R. S., Fort, P. E., Antonetti, D. A., & Gardner, T. W. (2006) · Diabetes · doi:10.2337/diabetes.55.04.06.db05-0744 · Cited by 174
Widegren, U., Ryder, J. W., & Zierath, J. R. (2001) · Acta Physiologica Scandinavica · doi:10.1046/j.1365-201x.2001.00855.x · Cited by 178
Self-citationWang, Z. G., Wang, Q., Wang, W.-Z., & Qin, H. (2010) · British journal of surgery · doi:10.1002/bjs.6963 · Cited by 175
Increased collagen content in insulin-resistant skeletal muscle
Berria, R., Wang, L., Richardson, D. K., Finlayson, J., Belfort, R., Pratipanawatr, T., De Filippis, E. A., Kashyap, S., & Mandarino, L. J. (2006) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00202.2005 · Cited by 171
Defective Signaling Through Akt-2 and -3 But Not Akt-1 in Insulin-Resistant Human Skeletal Muscle
Brozinick, J. T., Roberts, B. R., & Dohm, G. L. (2003) · Diabetes · doi:10.2337/diabetes.52.4.935 · Cited by 164
Enhanced Mitogenic Signaling in Skeletal Muscle of Women With Polycystic Ovary Syndrome
Corbould, A. M., Zhao, H., Mirzoeva, S., Aird, F., & Dunaif, A. E. (2006) · Diabetes · doi:10.2337/diabetes.55.03.06.db05-0453 · Cited by 166
Insulin signaling and glucose transport in insulin resistant human skeletal muscle
Karlsson, H. K. R., & Zierath, J. R. (2007) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-007-0030-9 · Cited by 159
Self-citationColistin and rifampicin in the treatment of multidrug-resistant Acinetobacter baumannii infections
Bassetti, M., Repetto, E. C., Righi, E., Boni, S., Diverio, M., Molinari, M. P., Mussap, M., Artioli, S., Ansaldi, F., Durando, P., et al. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm509 · Cited by 162
Coronary Vasomotor Abnormalities in Insulin-Resistant Individuals
Quiñones, M. J., Hernandez‐Pampaloni, M., Schelbert, H., Bulnes‐Enriquez, I., Jimenez, X., Hernandez, G., Rosa, R. D. L., Chon, Y., Yang, H., Nicholas, S. B., et al. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-140-9-200405040-00009 · Cited by 163
Kim, Y., Kotani, K., Ciaraldi, T. P., Henry, R. R., & Kahn, B. B. (2003) · Diabetes · doi:10.2337/diabetes.52.8.1935 · Cited by 159
Ryder, J. W., Chibalin, A., & Zierath, J. R. (2001) · Acta Physiologica Scandinavica · doi:10.1046/j.1365-201x.2001.00827.x · Cited by 158
Self-citationSystemic and mitochondrial adaptive responses to moderate exercise in rodents
Boveris, A., & Navarro, A. (2007) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2007.08.015 · Cited by 154
Wang, H., Zhang, Q., Wen, Q. J., Zheng, Y., Lazarovici, P., Jiang, H., Lin, J., & Zheng, W. (2011) · Cellular Signalling · doi:10.1016/j.cellsig.2011.08.010 · Cited by 156
Sending the Signal: Molecular Mechanisms Regulating Glucose Uptake
Krook, A., Wallberg‐Henriksson, H., & Zierath, J. R. (2004) · Medicine & Science in Sports & Exercise · doi:10.1249/01.mss.0000132387.25853.3b · Cited by 152
Self-citationAkt activation: A potential strategy to ameliorate insulin resistance
Zhang, Z., Liu, H., & Liu, J. (2017) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2017.10.004 · Cited by 143
Nair, S., Jayabalan, N., Guanzon, D., Palma, C., Scholz‐Romero, K., Elfeky, O. W. M., Zuñiga, F. A., Ormazábal, V., Diaz, E., Rice, G. E., et al. (2018) · Clinical Science · doi:10.1042/cs20180487 · Cited by 146
Cartee, G. D. (2015) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00416.2015 · Cited by 146
Ozanne, S. E., & Hales, C. N. (2003) · Diabetologia · doi:10.1007/s00125-003-1131-7 · Cited by 137
Henriksen, E. J. (2006) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2005.04.002 · Cited by 136
Goldfine, I. D., Maddux, B. A., YOUNGREN, J. F., Reaven, G. M., Accili, D., Trischitta, V., Vigneri, R., & Frittitta, L. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0004 · Cited by 137
Mitochondrial Dysfunction in Type 2 Diabetes and Obesity
Højlund, K., Mogensen, M., Sahlin, K., & Beck-Nielsen, H. (2008) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2008.06.006 · Cited by 135
Ryder, J. W., Bassel‐Duby, R., Olson, E. N., & Zierath, J. R. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m304510200 · Cited by 135
Self-citationModulation of metabolic control by angiotensin converting enzyme (ACE) inhibition
Henriksen, E. J., & Jacob, S. (2003) · Journal of Cellular Physiology · doi:10.1002/jcp.10294 · Cited by 132
Mechanisms regulating phosphoinositide 3‐kinase signalling in insulin‐sensitive tissues
Shepherd, P. R. (2005) · Acta Physiologica Scandinavica · doi:10.1111/j.1365-201x.2004.01382.x · Cited by 132
In Vivo Actions of Peroxisome Proliferator–Activated Receptors
Eldor, R., DeFronzo, R. A., & Abdul‐Ghani, M. A. (2013) · Diabetes Care · doi:10.2337/dcs13-2003 · Cited by 128
Öst, A., Danielsson, A., Lidén, M., Eriksson, U., Nyström, F. H., & Strålfors, P. (2007) · The FASEB Journal · doi:10.1096/fj.07-8173com · Cited by 126
Improvement of insulin sensitivity by antagonism of the renin-angiotensin system
Henriksen, E. J. (2007) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00147.2007 · Cited by 127
Lebeche, D., Davidoff, A. J., & Hajjar, R. J. (2008) · Nature Clinical Practice Cardiovascular Medicine · doi:10.1038/ncpcardio1347 · Cited by 122
Exercise in the Metabolic Syndrome
Golbidi, S., Mesdaghinia, A., & Laher, I. (2012) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2012/349710 · Cited by 127
Regulation of glucose transport in human skeletal muscle
Koistinen, H. A., & Zierath, J. R. (2002) · Annals of Medicine · doi:10.1080/078538902321012351 · Cited by 124
Self-citationProtein Kinase C and Lipid‐Induced Insulin Resistance in Skeletal Muscle
Schmitz‐Peiffer, C. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04272.x · Cited by 124
Pratipanawatr, W., Pratipanawatr, T., Cusi, K., Berria, R., Adams, J. M., Jenkinson, C. P., Maezono, K., DeFronzo, R. A., & Mandarino, L. J. (2001) · Diabetes · doi:10.2337/diabetes.50.11.2572 · Cited by 118
Desrois, M. (2003) · Cardiovascular Research · doi:10.1016/j.cardiores.2003.11.021 · Cited by 118
Enhanced Skeletal Muscle for Effective Glucose Homeostasis
Yang, J. (2014) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-800101-1.00005-3 · Cited by 122
Bulhak, A., Jung, C., Östenson, C., Lundberg, J. O., Sjöquist, P.-O. B., & Pernow, J. (2009) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00394.2008 · Cited by 116
Immunocytochemical Detection of Phosphatidylinositol 3-kinase Activation by Insulin and Leptin
Niswender, K. D., Gallis, B. M., Blevins, J. E., Corson, M. A., Schwartz, M. W., & Baskin, D. G. (2003) · Journal of Histochemistry & Cytochemistry · doi:10.1177/002215540305100302 · Cited by 115
Dietary Flavonoids in the Prevention of T2D: An Overview
Alkhalidy, H., Wang, Y., & Liu, D. (2018) · Nutrients · doi:10.3390/nu10040438 · Cited by 123
Absence of functional insulin receptor substrate-3 ( IRS-3 ) gene in humans
rnholm, M. B. X. F., He, A., Attersand, A., Lake, S., Liu, S., Lienhard, G. E., Taylor, S. I., Arner, P., & Zierath, J. R. (2002) · Diabetologia · doi:10.1007/s00125-002-0945-z · Cited by 116
Self-citationNikolić, N., Görgens, S. W., Thoresen, G. H., Aas, V., Eckel, J., & Eckardt, K. (2016) · Acta Physiologica · doi:10.1111/apha.12830 · Cited by 122
Pirola, L., Bonnafous, S., Johnston, A., Chaussade, C., Portis, F., & OBBERGHEN, E. V. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m208984200 · Cited by 110
Hall, L. M. L., Moran, C. N., Milne, G. R., Wilson, J., MacFarlane, N. G., Forouhi, N. G., Hariharan, N., Salt, I. P., Sattar, N., & Gill, J. M. R. (2010) · PLoS ONE · doi:10.1371/journal.pone.0014197 · Cited by 106
Burn injury impairs insulin-stimulated Akt/PKB activation in skeletal muscle
Sugita, H., Kaneki, M., Sugita, M., Yasukawa, T., Yasuhara, S., & Martyn, J. A. J. (2004) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00321.2004 · Cited by 110
Lasram, M. M., Dhouib, I. B., Annabi, A. B., Fazâa, S. E., & Gharbi, N. (2014) · Toxicology · doi:10.1016/j.tox.2014.04.009 · Cited by 108
Cozzone, D., Fröjdö, S., Disse, E., Debard, C., Laville, M., Pirola, L., & Vidal, H. (2008) · Diabetologia · doi:10.1007/s00125-007-0913-8 · Cited by 111
Shelley, P., Martin‐Gronert, M. S., Rowlerson, A. M., Poston, L., Heales, S., Hargreaves, I. P., McConnell, J. M. L., Ozanne, S. E., & Fernandez‐Twinn, D. S. (2009) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00146.2009 · Cited by 110
Koistinen, H. A., Chibalin, A., & Zierath, J. R. (2003) · Diabetologia · doi:10.1007/s00125-003-1196-3 · Cited by 108
Self-citationJin, W., Goldfine, A. B., Boes, T., Henry, R. R., Ciaraldi, T. P., Kim, E. Y., Şanlı, M. E., Fitzpatrick, C., Sen, A., Shah, A. M., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci41940 · Cited by 107
Tissue‐specific insulin signaling in the regulation of metabolism and aging
Zhang, J., & Liu, F. (2014) · IUBMB Life · doi:10.1002/iub.1293 · Cited by 105
Protein Kinase D1 Stimulates MEF2 Activity in Skeletal Muscle and Enhances Muscle Performance
Kim, M.-S., Fielitz, J., McAnally, J., Shelton, J. M., Lemon, D. D., McKinsey, T. A., Richardson, J. A., Bassel‐Duby, R., & Olson, E. N. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.00189-08 · Cited by 104
Potential new treatments for type 2 diabetes
Bailey, C. J. (2000) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01506-6 · Cited by 102
Genetic and nutrient determinants of the metabolic syndrome
Phillips, C. M., López‐Miranda, J., Pérez‐Jiménez, F., McManus, R., & Roche, H. M. (2006) · Current Opinion in Cardiology · doi:10.1097/01.hco.0000221579.25878.11 · Cited by 99
Characterization of a Protein Kinase B Inhibitor In Vitro and in Insulin-Treated Liver Cells
Logie, L., Ruiz‐Alcaraz, A. J., Keane, M. P., Woods, Y. L., Bain, J., Márquez, R., Alessi, D. R., & Sutherland, C. D. (2007) · Diabetes · doi:10.2337/db07-0343 · Cited by 100
Budge, H., Gnanalingham, M. G., Gardner, D. S., Mostyn, A., Stephenson, T. J., & Symonds, M. E. (2005) · Birth Defects Research Part C Embryo Today Reviews · doi:10.1002/bdrc.20044 · Cited by 95
Metadata
- Authors
- Krook, A., Björnholm, M., Galuska, D., Jiang, X. J., Fahlman, R., Myers, M. G., Wallberg-Henriksson, H., & Zierath, J. R.
- Affiliations
- Karolinska University Hospital (SE)
- Department of Clinical Physiology, Karolinska Hospital, Stockholm, Sweden.
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2000-02-01
- Volume
- 49
- Issue
- 2
- Pages
- 284-292
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2124948826
- Cited by
- 375
- References
- 19
- Citations by year
- 2026: 4 · 2025: 7 · 2024: 10 · 2023: 5 · 2022: 5 · 2021: 13 · 2020: 7 · 2019: 6 · 2018: 20 · 2017: 11 · 2016: 11 · 2015: 13 · 2014: 15 · 2013: 12 · 2012: 13
- FWCI
- 8.55
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Diabetes (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Keywords
- type 2 diabetes, skeletal muscle, insulin signaling, insulin receptor, IRS-1, insulin receptor substrate 2, phosphatidylinositol 3-kinase, glucose transport, mitogen-activated protein kinase, glycogen synthase, tyrosine phosphorylation, insulin resistance
- MeSH terms
- Biological Transport, Diabetes Mellitus, Type 2, Glucose, Glycogen Synthase, Humans, Insulin, Male, Middle Aged, Phosphoproteins, Phosphorylation, Receptor, Insulin, Time Factors, Tyrosine, Signal Transduction, Muscle, Skeletal, Phosphotyrosine, Phosphatidylinositol 3-Kinases, Mitogen-Activated Protein Kinases, Insulin Receptor Substrate Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review